Atlas · Symbols · Stocks & Shares · SCI
Equity · United States

SERVICE CORP INTERNATIONAL SCI

SERVICE CORP INTERNATIONAL is a services-personal services issuer listed as SCI on NYSE. This free Atlas page links SEC CIK 89089, Nasdaq Trader and TradingView NYSE:SCI, related symbols and the workstation route before a full report is run.

At a glance

SCI public profile

Business

Services-personal services issuer. Atlas tracks SCI through its NYSE listing record, chart route and source links.

Listing

SCI trades on NYSE. SEC CIK 89089. Chart route NYSE:SCI.

Browse

Nasdaq Trader is the listing identity source for SERVICE CORP INTERNATIONAL. Atlas files SCI under USA Stocks for browsing. The canonical public URL is /stocks/SCI/. The workstation link below opens the fuller research run.

Market Wit preview

The last time Service Corporation International filed its 10-Q for the quarter ending March 31 2026 it listed $1.10 billion in revenues, $135.8 million in net income, and $258 million in cash and equivalents-numbers that look tidy until you notice the inventory line sits at a mere $38.4 million. That $38 million pile of caskets, urns, and memorial products is what keeps the lights on after the last funeral of the day, yet the company is authorised to spend $472 million more on share buybacks, roughly twelve times its entire inventory value. It's the kind of arithmetic that turns shareholder capital into abstract numbers faster than a preacher can say 'ashes to ashes' (source: 10-Q, period ending 2026-03-31...

Run the full workstation report for the complete source rail, saved history, export controls, and the full Market Wit file for SCI.

Run full research Go Atlas Pro

Daily answer

What changed for SERVICE CORP INTERNATIONAL today

Open full report
SCI daily contextvalidated public digest16 source rail2026-06-19 06:45 UTC

Service Corporation International filed its 10-Q for the quarter ending 31 March 2026 showing $1.10 billion in revenues, $135.8 million in net income to the parent, and $258 million in cash and equivalents on the balance sheet. Operating income stood at $243.8 million, while total assets reached $18.57 billion-dominated by goodwill and cemetery land rather than inventory, which clocked in at just $38.4 million. The company also reported $1.58 billion in stockholders’ equity and $333.8 million in net cash provided by operating activities, alongside diluted earnings per share of $0.97 across 139.9 million diluted shares.

Founded in 1962 and headquartered in Houston, SCI is the largest provider of deathcare services in North America, operating over 1,500 funeral homes and 500 cemeteries across the United States and Canada. The company’s core offering-funeral services, cemetery property sales, cremation, and memorialisation-turns an unavoidable human event into a recurring revenue stream, a model that has historically delivered steady cash flows but also invites scrutiny over how much sentiment can be monetised without inviting regulatory or reputational friction.

The numbers in the 10-Q tell the operational story: high-margin cash generation from funeral services and cemetery sales, low working-capital intensity thanks to pre-need contracts, and a balance sheet that leans heavily on intangible assets rather than hard inventory. Cash flow from operations of $333.8 million underscores the durability of the model, while the $38.4 million inventory figure-mostly caskets, urns, and memorial products-serves as a sober reminder that the business still deals in physical goods, even if the emotional payload is the real product. Diluted EPS of $0.97 on 139.9 million shares looks unremarkable until you consider the shareholder base that has grown accustomed to buybacks as a primary capital-return tool. Shareholders are buying the story of recurring revenue, but the company keeps buying the shares.

On 11 June 2026, SCI issued an 8-K announcing an expansion of its existing share repurchase program, authorising an additional $472 million in buybacks and bringing the total available under the program to approximately $1.1 billion. The move follows a spate of insider filings on 13 May 2026, including Forms 3 and 4 for several directors and executives, indicating ongoing changes in beneficial ownership and incentive alignment. The 8-K frames the buyback as opportunistic in light of the company’s cash generation and valuation, but the optics are hard to ignore: a business whose core product is finality is now allocating more capital to finalising its own share count than to expanding capacity in a sector where land and regulatory approval are the real bottlenecks.

For context, the company’s 10-Q balance sheet shows $258 million in cash and equivalents against $18.57 billion in total assets, and the $472 million buyback authorization is roughly 1.8 times the company’s entire cash pile. That ratio raises a simple question: is the board optimising for shareholder returns, or is it signalling confidence in a business model that may have already harvested most of the secular tailwinds in North American deathcare? The answer lies less in the filings and more in the next cemetery expansion cycle, the regulatory climate around pre-need trusts, and the pace at which cremation penetrates a market still wedded to traditional burials. Until then, the buyback is the headline, the caskets are in the warehouse, and the land is already spoken for.

On the liquidity front, SCI reported $333.8 million in net cash provided by operating activities for Q1 2026, a figure that speaks to the cash-generative nature of the model but also masks the seasonality of cemetery land sales and the lumpiness of funeral-service revenue recognition. The $38.4 million inventory line-split between finished goods and work-in-progress-is a rounding error against the $1.1 billion revenue base, yet it represents the physical manifestation of a business that, at its core, sells memorialisation as a service wrapped around a product. The company’s ability to turn grief into recurring revenue is the real asset; the caskets on the shelf are just the props. The recent insider filings suggest a reshuffle at the top, but the filings themselves don’t reveal whether the changes are driven by growth ambitions, succession planning, or a strategic pivot toward adjacencies like pet memorialisation or digital memorialisation services-areas where the evidence remains silent.

What we know for certain is that SCI’s $472 million buyback authorization lands in a sector where land scarcity, zoning laws, and regulatory oversight make greenfield expansion costly and time-consuming. The company’s existing footprint is already extensive-over 1,500 funeral homes and 500 cemeteries-so the buyback is less about capacity expansion and more about capital discipline and valuation arbitrage. The tension sits in the gap between the company’s cash-generative model and the finite supply of cemetery land, a constraint that could eventually force a rethink of the entire deathcare value chain. Until then, the shares are being repurchased, the filings are being filed, and the caskets are sitting quietly in inventory, waiting for the next inevitable departure.

This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.

Ticker
SCI
Exchange
NYSE
Sector
Us Public Equity Directory
Region
United States
Asset class
Equity
Directory source
Nasdaq Trader
SEC CIK
TradingView
Source authority

SCI evidence rails

Atlas uses the specific public rails available for SCI: SEC EDGAR, Nasdaq Trader, TradingView, FRED. Source names identify evidence routes and tools; no partnership, sponsorship or endorsement is implied.

TradingView chart NYSE:SCI

Atlas has no approved static OHLC cache attached for SCI yet, so the profile renders the verified TradingView chart route directly and keeps the full-chart link as fallback.

Open full TradingView chart ->

Run an Atlas research workflow on SCI

FreedomCore Atlas operates research workstation templates for company snapshots, DCF, LBO, KYC, NAV tie-outs, and council-grade equity briefs. Each workflow uses public-source filings and structured prompts.

Open Atlas workstation ->
Atlas Pro

Save SCI research and exports

Free Atlas users can run full browser research reports from the workstation. Atlas Pro adds 25 custom runs a day, saved research history, email delivery, PDF/CSV exports, and a 25-symbol watchlist. £12/mo founding price, locked for life. Research only; not investment advice.

Checking Atlas access...

SCI FAQ

What is SERVICE CORP INTERNATIONAL (SCI)?SERVICE CORP INTERNATIONAL is a services-personal services issuer listed as SCI on NYSE. This free Atlas page links SEC CIK 89089, Nasdaq Trader and TradingView...

SERVICE CORP INTERNATIONAL is a services-personal services issuer listed as SCI on NYSE. This free Atlas page links SEC CIK 89089, Nasdaq Trader and TradingView NYSE:SCI, related symbols and the workstation route before a full report is run.

What does Atlas show for SCI?The SCI page gives the free Atlas profile for SERVICE CORP INTERNATIONAL: listing identity, chart route, related symbols, source authority and the workstation route....

The SCI page gives the free Atlas profile for SERVICE CORP INTERNATIONAL: listing identity, chart route, related symbols, source authority and the workstation route. The chart route is NYSE:SCI; the stable page route is /stocks/SCI/. Visible source links include SEC EDGAR CIK 89089, Nasdaq Trader and TradingView NYSE:SCI. Atlas files SCI under USA Stocks for browsing.

How often is the SCI page updated?The /stocks/SCI/ URL is stable. Atlas updates the free SCI page when the symbol-universe record, listing identity, source links, chart route, related-symbol links or...

The /stocks/SCI/ URL is stable. Atlas updates the free SCI page when the symbol-universe record, listing identity, source links, chart route, related-symbol links or published public answer changes.

Which sources does Atlas use for SCI?For SCI, Atlas starts with SEC EDGAR CIK 89089, Nasdaq Trader and TradingView NYSE:SCI. The SEC CIK 89089 route is the issuer filing anchor. Nasdaq Trader confirms the...

For SCI, Atlas starts with SEC EDGAR CIK 89089, Nasdaq Trader and TradingView NYSE:SCI. The SEC CIK 89089 route is the issuer filing anchor. Nasdaq Trader confirms the listed-symbol identity used by the public directory. NYSE:SCI is the chart route shown on the free page. Full workstation reports may add fresh filings, issuer documents, holdings, news, macro context or model-reviewed notes when available.

Can Atlas run a full research brief on SCI?Yes. The workstation can open SCI, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Yes. The workstation can open SCI, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Is this SCI page investment advice?No. The SCI page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a buy or sell instruction, or a...

No. The SCI page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a buy or sell instruction, or a promise of returns.

Methodology

This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link.

Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.

Profile last updated: 2026-06-19. Browse FreedomCore Atlas research notes →